National Research (NRC) Projected Price to Earnings

The price action of National Research (NRC) securities reflects a multiple currently equal to 0.00. National Research is implementing digital tools for clinics, leveraging stable subscription payments and the loyalty of major networks. However, the business faces potential cuts in government spending on analytics and pressure from integrated software, which creates certain risks for its market share.

NRC - NRC Health Inc. Market Cap to Projected Earnings over the range 07/04/2022 - 11/12/2026

nrchealth.com (NRC) - metric breakdowns and financial figures

- stock quotes and analyst forecast:

Stock Price National Research Corp.|NRC - Analyst Consensus Forecast

- market capitalization details:

Market Valuation National Research Corp|NRC - Aggregate Business Value

- issuer book value statistics:

Book Value per Share NRC Health|NRC - Book Valuation of Business|Market Value to Book Value Ratio nrchealth.com|NRC - Company Assets

- debt and solvency information:

- earnings and market ratios statistics:

NRC - Final Profit|Projected Future Earnings National Research|NRC - Market Cap to Earnings|Future Price to Earnings NRC Health Inc.|NRC - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple National Research Corp|NRC - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) NRC Health|NRC - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months nrchealth.com|NRC - Earnings per share increase in current year|Earnings growth forecast for next year National Research

Comprehensive company analysis:NRC National Research Corp

The indicator's dynamics depend directly on the business's expected operational efficiency. This metric compares the current market share price with the projected earnings per share. The growth of National Research (NRC) digital medical feedback platforms must convert into scalable profit. Excessively low values may indicate market skepticism regarding future revenues. Analyze the forward P/E based on company analyst estimates to determine fair value.

Competing companies